May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Soluble Forms of EphB4 and EphrinB2 Reduce Neovascular Tuft Formation in the Mouse Model of ROP: Novel Targets to Inhibit Angiogenesis
Author Affiliations & Notes
  • D.O. Zamora
    Cell Biology,
    Casey Eye Institute, Oregon Health & Science University, Portland, OR
  • M.H. Davies
    Pediatrics,
    Casey Eye Institute, Oregon Health & Science University, Portland, OR
  • L. Simmons
    Ophthalmology,
    Casey Eye Institute, Oregon Health & Science University, Portland, OR
  • M.T. Montanaro
    Ophthalmology,
    Casey Eye Institute, Oregon Health & Science University, Portland, OR
  • S.R. Planck
    Cell Biology,
    Casey Eye Institute, Oregon Health & Science University, Portland, OR
  • J.T. Rosenbaum
    Ophthalmology,
    Casey Eye Institute, Oregon Health & Science University, Portland, OR
  • M.R. Powers
    Pediatrics,
    Casey Eye Institute, Oregon Health & Science University, Portland, OR
  • Footnotes
    Commercial Relationships  D.O. Zamora, None; M.H. Davies, None; L. Simmons, None; M.T. Montanaro, None; S.R. Planck, None; J.T. Rosenbaum, None; M.R. Powers, None.
  • Footnotes
    Support  NIH Grants: EY011548, EY07123, EY06484, EY10572 and Research to Prevent Blindness
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4649. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      D.O. Zamora, M.H. Davies, L. Simmons, M.T. Montanaro, S.R. Planck, J.T. Rosenbaum, M.R. Powers; Soluble Forms of EphB4 and EphrinB2 Reduce Neovascular Tuft Formation in the Mouse Model of ROP: Novel Targets to Inhibit Angiogenesis . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4649.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: EphB4 (B4) receptors and their EphrinB2 (B2) ligands are key regulators of cell migration during development and help regulate venule–arteriole boundaries. We hypothesize that these molecules play a role in neovascularization (NV) in the mouse model of oxygen–induced retinopathy and that soluble versions of these molecules can potentially alter the pathologic neovascular response in this disease. Methods: C57BL/6 mice at postnatal day 7 (P7) were exposed to 75% oxygen (O2) for 5 days (P12) and allowed to recover in room air to induce retinal NV. Retinas from O2 exposed mice (n=4) and unexposed control mice (n=4) were obtained at Ps: 7, 8, 10, 12, 14, 17, 21, 24 and analyzed for B4 and B2 mRNA expression by RT–PCR. Some O2 exposed mice had one eye–injected intravitreally with 150ng in 1.5µls of soluble B4/IgG–Fc chimera (n=12) or B2/IgG–Fc chimera (n=13) during transition to room air (P12) and reinjected at P14. Contralateral eyes were injected with IgG antibodies as control (n=25). All injected eyes were collected during peak disease (P17) and processed for quantification of preretinal nuclei and labeling of blood vessels with anti–type IV collagen antibodies. Results: B4 mRNA was detected in the retinas of control mice at all time points, peaking at P12–P14, and decreasing back to initial levels by P17–P24. Interestingly, exposing mice to O2 shifted B4’s peak expression to P14–P21. By P24, B4 mRNA levels were the same in O2 and control mouse retinas. In contrast, B2 mRNA remained constant through P7–P24 in both O2 and control mouse retinas. The number of preretinal nuclei in O2 exposed mice was reduced by 66% (p<0.05) in B4 injected eyes and by 69% (p<0.05) in B2 injected eyes, as compared to control injections. There was no apparent alteration of intraretinal vascular development by the injections. Conclusions: B4 and B2 are expressed in the developing mouse retina, with B4’s expression being altered in O2 injured retinas. Treatment with either soluble B4 or B2 significantly reduced the extent of O2 induced NV. These results support the hypothesis that B4 and B2 are regulators of retinal NV during ROP and may serve as novel targets for therapeutic intervention.

Keywords: retinal neovascularization 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×